FR2464715A1 - Utilisation de derives de glycerylphosphoryle dans la therapie des dyslipemies, des hepatites et des etats pathologiques analogues et compositions pharmaceutiques pour cette therapie - Google Patents
Utilisation de derives de glycerylphosphoryle dans la therapie des dyslipemies, des hepatites et des etats pathologiques analogues et compositions pharmaceutiques pour cette therapie Download PDFInfo
- Publication number
- FR2464715A1 FR2464715A1 FR8001004A FR8001004A FR2464715A1 FR 2464715 A1 FR2464715 A1 FR 2464715A1 FR 8001004 A FR8001004 A FR 8001004A FR 8001004 A FR8001004 A FR 8001004A FR 2464715 A1 FR2464715 A1 FR 2464715A1
- Authority
- FR
- France
- Prior art keywords
- glycerylphosphoryl
- derivatives
- glycerylphosphorylcholine
- therapy
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT25706/79A IT1123142B (it) | 1979-09-14 | 1979-09-14 | Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2464715A1 true FR2464715A1 (fr) | 1981-03-20 |
FR2464715B1 FR2464715B1 (nl) | 1983-07-22 |
Family
ID=11217502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8001004A Granted FR2464715A1 (fr) | 1979-09-14 | 1980-01-17 | Utilisation de derives de glycerylphosphoryle dans la therapie des dyslipemies, des hepatites et des etats pathologiques analogues et compositions pharmaceutiques pour cette therapie |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5643212A (nl) |
AU (1) | AU520245B2 (nl) |
BE (1) | BE881071A (nl) |
CH (1) | CH645543A5 (nl) |
DE (1) | DE3000139C2 (nl) |
FR (1) | FR2464715A1 (nl) |
GB (1) | GB2057872B (nl) |
IT (1) | IT1123142B (nl) |
NL (1) | NL179873C (nl) |
ZA (1) | ZA796882B (nl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1199972B (it) * | 1985-05-08 | 1989-01-05 | Lpb Ist Farm | Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale |
DE3671630D1 (de) * | 1985-07-03 | 1990-07-05 | Cl Pharma | Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate. |
IT1213034B (it) * | 1986-02-12 | 1989-12-07 | Istituto Chemioterapico Di Lod | Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale. |
IT1212137B (it) * | 1987-04-08 | 1989-11-08 | Rosanna Lodi | Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali. |
EP0329053A1 (en) * | 1988-02-15 | 1989-08-23 | MAGIS FARMACEUTICI S.p.A. | Choline esters of glycerophosphoric acids |
EP0348859A1 (en) * | 1988-07-01 | 1990-01-03 | MAGIS FARMACEUTICI S.p.A. | 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them |
IT1230140B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Derivati della serina, loro processo di preparazione e impiego in terapia umana |
JP4891522B2 (ja) * | 2003-10-03 | 2012-03-07 | 株式会社ファンケル | 血清got、gpt改善剤 |
CN102138892B (zh) * | 2010-02-03 | 2014-07-30 | 广州汉光医药进出口有限公司 | 甘磷酸胆碱注射制剂及其配制方法和检测方法 |
JP2014051459A (ja) * | 2012-09-07 | 2014-03-20 | Nof Corp | 脂質代謝促進剤 |
CN116966191A (zh) * | 2022-04-22 | 2023-10-31 | 深圳先进技术研究院 | 甘油磷酸胆碱在调控细胞nad+水平和分布中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907778A1 (de) * | 1978-02-28 | 1979-08-30 | Nippon Shoji Kaisha Ltd | Verwendung von phosphatidylverbindungen in arzneimitteln gegen wahrnehmungs-, bewusstseins- und bewegungsstoerungen |
-
1979
- 1979-09-14 IT IT25706/79A patent/IT1123142B/it active
- 1979-12-12 GB GB7942835A patent/GB2057872B/en not_active Expired
- 1979-12-13 AU AU53792/79A patent/AU520245B2/en not_active Ceased
- 1979-12-19 ZA ZA00796882A patent/ZA796882B/xx unknown
- 1979-12-27 JP JP17397479A patent/JPS5643212A/ja active Granted
-
1980
- 1980-01-04 DE DE3000139A patent/DE3000139C2/de not_active Expired
- 1980-01-09 NL NLAANVRAGE8000140,A patent/NL179873C/nl not_active IP Right Cessation
- 1980-01-10 BE BE2/58326A patent/BE881071A/fr not_active IP Right Cessation
- 1980-01-17 FR FR8001004A patent/FR2464715A1/fr active Granted
- 1980-02-05 CH CH89980A patent/CH645543A5/it not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907778A1 (de) * | 1978-02-28 | 1979-08-30 | Nippon Shoji Kaisha Ltd | Verwendung von phosphatidylverbindungen in arzneimitteln gegen wahrnehmungs-, bewusstseins- und bewegungsstoerungen |
Non-Patent Citations (1)
Title |
---|
CA1970 * |
Also Published As
Publication number | Publication date |
---|---|
IT1123142B (it) | 1986-04-30 |
DE3000139C2 (de) | 1986-05-22 |
BE881071A (fr) | 1980-05-02 |
GB2057872B (en) | 1984-01-11 |
JPH0121132B2 (nl) | 1989-04-19 |
GB2057872A (en) | 1981-04-08 |
AU520245B2 (en) | 1982-01-21 |
AU5379279A (en) | 1981-04-02 |
ZA796882B (en) | 1980-11-26 |
IT7925706A0 (it) | 1979-09-14 |
FR2464715B1 (nl) | 1983-07-22 |
NL179873B (nl) | 1986-07-01 |
NL179873C (nl) | 1986-12-01 |
NL8000140A (nl) | 1981-03-17 |
DE3000139A1 (de) | 1981-04-02 |
CH645543A5 (it) | 1984-10-15 |
JPS5643212A (en) | 1981-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3008213B2 (ja) | 医薬組成物 | |
JP2722227B2 (ja) | 脂肪酸組成物 | |
US20050267212A1 (en) | Omega-3 fatty acids in the treatment of depression | |
JPS6296422A (ja) | 子宮内膜増殖症予防または治療用組成物の製造方法およびその来成物を用いる前記増殖症の予防または治療方法 | |
JPH02500107A (ja) | 即効性/強化された鎮痛作用 | |
ES2585066T3 (es) | Composiciones para el tratamiento de trastornos neurológicos | |
EP0336851A1 (fr) | Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique | |
FR2464715A1 (fr) | Utilisation de derives de glycerylphosphoryle dans la therapie des dyslipemies, des hepatites et des etats pathologiques analogues et compositions pharmaceutiques pour cette therapie | |
FR2530468A1 (fr) | Composition analgesique et anti-inflammatoire contenant de l'ibuprofen | |
MX2014000971A (es) | Agente mejorador de la funcion diastolica ventricular izquierda. | |
JPS5841821A (ja) | 最少化された胃の損傷を示す抗炎症組成物 | |
FR2482588A1 (fr) | Composition pharmaceutique pour le traitement du diabete sucre juvenile | |
EP1206257A1 (fr) | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances | |
BE1007024A5 (fr) | Compositions a activite agoniste des recepteurs analogues a 5ht1, selective. | |
JP3092180B2 (ja) | 低密度リポ蛋白受容体活性化剤 | |
JPH0529206B2 (nl) | ||
JP2008521888A (ja) | 脂肪症の、又は肝毒性及びその後遺症の治療及び予防におけるスフィンゴ脂質 | |
CN101652134A (zh) | 用于预防和/或治疗脂肪肝或非酒精性脂肪性肝炎的药物 | |
FR2705569A1 (fr) | Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale. | |
JP2011063623A (ja) | 耐糖能異常用医薬組成物及び飲食品 | |
AU2005244483B2 (en) | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease | |
FR2515962A1 (fr) | Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie | |
US4242360A (en) | Choleretic pharmaceutical compositions and method of treatment | |
JP3177686B2 (ja) | 月経困難症予防または治療剤と月経困難症予防機能性食品 | |
BE829197A (fr) | Compositions anti-inflammatoires, leur preparation et leur utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |